We are live on ! Find out more
TAK icon

Takeda Pharmaceutical
TAK

283 hedge funds and large institutions have $1.15B invested in Takeda Pharmaceutical in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 90 increasing their positions, 102 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

671% more call options, than puts

Call options by funds: $23.6M | Put options by funds: $3.06M

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

5% more capital invested

Capital invested by funds: $1.09B → $1.15B (+$58.3M)

0.39% less ownership

Funds ownership: 4.94% → 4.56% (-0.39%)

10% less funds holding

Funds holding: 313 → 283 (-30)

12% less repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 102

47% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 55

Holders
283
Holders Change
-30
Holders Change %
-9.58%
% of All Funds
4.09%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
29
Increased
90
Reduced
102
Closed
55
Calls
$23.6M
Puts
$3.06M
Net Calls
+$20.5M
Net Calls Change
-$3.89M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$26.8M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$12.6M
3
CAC
Cowen and Company
New York
+$7.02M
4
VanEck Associates
VanEck Associates
New York
+$4.71M
5
Citadel Advisors
Citadel Advisors
Florida
+$4.01M

Top Sellers

Rank Fund Capital Flow
1
MIP
Mondrian Investment Partners
United Kingdom
-$57.5M
2
Macquarie Group
Macquarie Group
Australia
-$15.9M
3
Bank of America
Bank of America
North Carolina
-$8.17M
4
BlackRock
BlackRock
New York
-$7.39M
5
Goldman Sachs
Goldman Sachs
New York
-$6.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
MFG
276
Mendota Financial Group
Wisconsin
$389 +$397 +30 New
AAG
277
Armstrong Advisory Group
Massachusetts
$324 – – –
SIS
278
Sound Income Strategies
Florida
$324 – – –
AF
279
Advisornet Financial
Minnesota
$259 – – –
AIP
280
Ameritas Investment Partners
Nebraska
$194 – – –
MG
281
Mather Group
Illinois
$56 -$384 -29 -88%
PFBT
282
Parkside Financial Bank & Trust
Missouri
$26 -$768 -58 -97%
Barclays
283
Barclays
United Kingdom
$26 – – –
D.E. Shaw & Co
284
D.E. Shaw & Co
New York
– -$4.92M -354,299 Closed
LP
285
LMR Partners
United Kingdom
– -$3.77M -271,143 Closed
Point72 Asset Management
286
Point72 Asset Management
Connecticut
– -$2.86M -206,100 Closed
Franklin Resources
287
Franklin Resources
California
– -$2.58M -185,572 Closed
PAM
288
Pinpoint Asset Management
Hong Kong
– -$2.05M -147,600 Closed
LWL
289
Leo Wealth LLC
Texas
– -$1.73M -124,449 Closed
Qube Research & Technologies (QRT)
290
Qube Research & Technologies (QRT)
United Kingdom
– -$1.59M -114,209 Closed
Rockefeller Capital Management
291
Rockefeller Capital Management
New York
– -$1.45M -104,543 Closed
N
292
Nuveen
North Carolina
– -$1.05M -74,190 Closed
Capital Fund Management (CFM)
293
Capital Fund Management (CFM)
France
– -$959K -69,026 Closed
Squarepoint
294
Squarepoint
New York
– -$927K -66,760 Closed
FIA
295
FNY Investment Advisers
New York
– -$860 -61,956 Closed
CI
296
Clal Insurance
Israel
– -$625K -45,000 Closed
XT
297
XTX Topco
Cayman Islands
– -$585K -42,116 Closed
ERSOT
298
Employees Retirement System of Texas
Texas
– -$550K -39,577 Closed
CP
299
Covenant Partners
Tennessee
– -$394K -28,340 Closed
CA
300
Centerpoint Advisors
Massachusetts
– -$375K -27,000 Closed
10 11
12
13 14

TAK Hedge Fund Activity: Q2 2024 in Review

283 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Takeda Pharmaceutical (TAK) for Q2 2024, worth a combined $1.15B — up 5.4% from $1.09B a quarter earlier.

Sellers outnumbered buyers: 55 funds closed out of TAK and 29 opened new positions — a net loss of 26 holders — while 102 trimmed existing stakes and 90 added.

The largest buyer was Millennium Management, adding an estimated $26.8M. The largest seller was Mondrian Investment Partners, cutting an estimated $57.5M.

  • 283 institutional investors held Takeda Pharmaceutical (TAK) as of Q2 2024, down from 313 in Q1 2024.
  • Funds reported $1.15B of Takeda Pharmaceutical stock for Q2 2024, up 5.4% quarter-over-quarter.
  • 29 funds opened new Takeda Pharmaceutical positions in Q2 2024 and 55 closed out, a net change of -26 holders.
  • The largest Takeda Pharmaceutical buyer in Q2 2024 was Millennium Management, an estimated $26.8M added.
  • The largest Takeda Pharmaceutical seller in Q2 2024 was Mondrian Investment Partners, an estimated $57.5M sold.

Based on aggregated 13F filings for Q2 2024.